Literature DB >> 25997948

Attenuation of Ca2+ homeostasis, oxidative stress, and mitochondrial dysfunctions in diabetic rat heart: insulin therapy or aerobic exercise?

Márcia F da Silva1, Antônio J Natali2, Edson da Silva3, Gilton J Gomes2, Bruno G Teodoro4, Daise N Q Cunha2, Lucas R Drummond2, Filipe R Drummond2, Anselmo G Moura2, Felipe G Belfort2, Alessandro de Oliveira2, Izabel R S C Maldonado1, Luciane C Alberici5.   

Abstract

We tested the effects of swimming training and insulin therapy, either alone or in combination, on the intracellular calcium ([Ca(2+)]i) homeostasis, oxidative stress, and mitochondrial functions in diabetic rat hearts. Male Wistar rats were separated into control, diabetic, or diabetic plus insulin groups. Type 1 diabetes mellitus was induced by streptozotocin (STZ). Insulin-treated groups received 1 to 4 UI of insulin daily for 8 wk. Each group was divided into sedentary or exercised rats. Trained groups were submitted to swimming (90 min/day, 5 days/wk, 8 wk). [Ca(2+)]i transient in left ventricular myocytes (LVM), oxidative stress in LV tissue, and mitochondrial functions in the heart were assessed. Diabetes reduced the amplitude and prolonged the times to peak and to half decay of the [Ca(2+)]i transient in LVM, increased NADPH oxidase-4 (Nox-4) expression, decreased superoxide dismutase (SOD), and increased carbonyl protein contents in LV tissue. In isolated mitochondria, diabetes increased Ca(2+) uptake, susceptibility to permeability transition pore (MPTP) opening, uncoupling protein-2 (UCP-2) expression, and oxygen consumption but reduced H2O2 release. Swimming training corrected the time course of the [Ca(2+)]i transient, UCP-2 expression, and mitochondrial Ca(2+) uptake. Insulin replacement further normalized [Ca(2+)]i transient amplitude, Nox-4 expression, and carbonyl content. Alongside these benefits, the combination of both therapies restored the LV tissue SOD and mitochondrial O2 consumption, H2O2 release, and MPTP opening. In conclusion, the combination of swimming training with insulin replacement was more effective in attenuating intracellular Ca(2+) disruptions, oxidative stress, and mitochondrial dysfunctions in STZ-induced diabetic rat hearts.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  Nox-4; diabetes mellitus; mitochondria; physical activity

Mesh:

Substances:

Year:  2015        PMID: 25997948     DOI: 10.1152/japplphysiol.00915.2014

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  5 in total

Review 1.  Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.

Authors:  Jake Russell; Eugene F Du Toit; Jason N Peart; Hemal H Patel; John P Headrick
Journal:  Cardiovasc Diabetol       Date:  2017-12-04       Impact factor: 9.951

Review 2.  Proarrhythmic Remodeling of Calcium Homeostasis in Cardiac Disease; Implications for Diabetes and Obesity.

Authors:  Shanna Hamilton; Dmitry Terentyev
Journal:  Front Physiol       Date:  2018-10-30       Impact factor: 4.566

3.  Transport of Ca2+ and Ca2+-Dependent Permeability Transition in Rat Liver Mitochondria under the Streptozotocin-Induced Type I Diabetes.

Authors:  Konstantin N Belosludtsev; Eugeny Yu Talanov; Vlada S Starinets; Alexey V Agafonov; Mikhail V Dubinin; Natalia V Belosludtseva
Journal:  Cells       Date:  2019-08-30       Impact factor: 6.600

Review 4.  Regulation of Vascular Function and Inflammation via Cross Talk of Reactive Oxygen and Nitrogen Species from Mitochondria or NADPH Oxidase-Implications for Diabetes Progression.

Authors:  Andreas Daiber; Sebastian Steven; Ksenija Vujacic-Mirski; Sanela Kalinovic; Matthias Oelze; Fabio Di Lisa; Thomas Münzel
Journal:  Int J Mol Sci       Date:  2020-05-12       Impact factor: 5.923

Review 5.  Can We Prevent Mitochondrial Dysfunction and Diabetic Cardiomyopathy in Type 1 Diabetes Mellitus? Pathophysiology and Treatment Options.

Authors:  Aleksandra Cieluch; Aleksandra Uruska; Dorota Zozulinska-Ziolkiewicz
Journal:  Int J Mol Sci       Date:  2020-04-19       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.